CAS: 2226534-49-0
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 5-[1-(Cyclohexylmethyl)-6-[(3S)-3-methylmorpholin-4-yl]benzimidazol-2-yl]-3-methyl-1,2-benzoxazole REF: 3D-BPD53449CAS: 2226534-49-0 | Min. 95% | Prezzo su richiesta | Ven 27 Dic 24 |
 | Y06137 REF: TM-T13363CAS: 2226534-49-0 | 97.27% | 60,00 €~669,00 € | Mar 28 Gen 25 |
![5-[1-(Cyclohexylmethyl)-6-[(3S)-3-methylmorpholin-4-yl]benzimidazol-2-yl]-3-methyl-1,2-benzoxazole](https://static.cymitquimica.com/products/3D/thumb/BPD53449.jpg)
5-[1-(Cyclohexylmethyl)-6-[(3S)-3-methylmorpholin-4-yl]benzimidazol-2-yl]-3-methyl-1,2-benzoxazole
CAS:2226534-49-0
5-[1-(Cyclohexylmethyl)-6-[(3S)-3-methylmorpholin-4-yl]benzimidazol-2-yl]-3-methyl-1,2-benzoxazole is a ligand that specifically binds to the dopamine D2 receptor. It is also …
Formula:
C27H32N4O2
Purezza:
Min. 95%
Peso molecolare:
444.6 g/mol
Ref: 3D-BPD53449
| 1mg | Prezzo su richiesta | ||
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024
Y06137
CAS:2226534-49-0
Y06137, selective BET inhibitor, Kd 81 nM for BRD4(1), researched for castration-resistant prostate cancer treatment.
Formula:
C27H32N4O2
Purezza:
97.27%
Colore e forma:
Solid
Peso molecolare:
444.57
Ref: TM-T13363
| 1mg | 60,00 € | ||
| 2mg | 86,00 € | ||
| 5mg | 126,00 € | ||
| 10mg | 201,00 € | ||
| 25mg | 374,00 € | ||
| 1mL*10mM (DMSO) | 140,00 € |
Consegna stimata in Stati Uniti, il Martedì 28 Gennaio 2025
